<DOC>
	<DOCNO>NCT00030979</DOCNO>
	<brief_summary>This study evaluate safety effectiveness donepezil ( Aricept ) treat mild dementia patient Parkinson 's disease . Donepezil approve treat patient Alzheimer 's disease , whose memory cognition problem similar patient Parkinson 's disease affect dementia . Donepezil prevent breakdown chemical messenger call acetylcholine , involved memory cognitive function , may improve cognition patient . Patients 40 year age old Parkinson 's disease mild moderate dementia may eligible 6-month study . It involve 6 clinic visit approximately 2 hour , describe . Candidates screen participation Visit 1 . - Visit 1 ( screen visit ) : Study candidate medical history , physical neurological examination , electrocardiogram ( EKG ) , possibly blood test . They also undergo neuropsychological testing ( test memory , language , mood , brain function ) fill quality life questionnaire . Those enrol randomly assign receive either donepezil ( 5 mg per day ) placebo-a look-alike pill active ingredient . After 4 week , dose donepezil increase 10 mg per day . Patients tolerate high dose reduce 5 mg. Those tolerate 5-mg dose take medication continue follow test . - Visit 2 ( week 7 ) : Patients neurological examination neuropsychological testing fill quality life questionnaire . - Visit 3 ( week 10 ) : Patients repeat evaluation do visit 2 stop taking study medication . - Visit 4 ( week 16 ) : Patients repeat evaluation do visit 2 study medication switch . That , patient previously placebo switched donepezil , patient take donepezil switch placebo . After 4 week , dose donepezil increase 10 mg per day . Patients tolerate high dose reduce 5 mg. Those tolerate 5-mg dose take medication continue follow test . - Visits 5 6 ( week 23 26 ) : Patients repeat evaluation do visit 2 . This study conduct National Institutes Health , University Pennsylvania , Northwestern University</brief_summary>
	<brief_title>Donepezil Treat Dementia Parkinson 's Disease</brief_title>
	<detailed_description>Parkinson 's disease ( PD ) second common neurodegenerative disorder Alzheimer 's disease ( AD ) . Dementia common problem late course disease effective therapy . Dementia severely impair patient '' functional status limit treatment motor manifestation PD . No effective therapy dementia PD available . The pathophysiology dementia PD completely understand , however , AD , think relate cholinergic dysfunction . The propose study determine whether therapeutic intervention donepezil , acetylcholinesterase inhibitor , show effective AD , improve cognitive function PD . The study plan 26-week , randomize , double-blind , placebo-controlled , cross-over study efficacy safety donepezil PD dementia . The study conduct University Pennsylvania , Brown University , Northwestern University NINDS . The primary outcome measure trial change Alzheimer 's Disease Assessment Scale-Cognitive Subscale ( ADAS-cog ) . The secondary outcome measure include scale cognitive function , activity daily live , mood , quality life . Tolerability drug assess base side effect profile , specifically , effect motor performance .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>INCLUSION CRITERIA : Age great equal 40 . A clinical diagnosis Idiopathic PD , stag IIV , use British Brain Bank Research Diagnostic Criteria . Mild moderate dementia Mini Mental Status Score 1726 . EXCLUSION CRITERIA : The presence alternative cause dementia AD stroke , base clinical evaluation . Subjects serologic screen reversible cause dementia , include syphilis , thyroid dysfunction B12 deficiency . Presence uncontrolled hallucinationshallucinations disruptive would interfere cognitive testing . Anticholinergic cholinergic therapy within 2 week prior inclusion study except Amantadine Detrol . Patients unstable clinically significant medical problem cardiac arrhythmia unstable heart disease ( e.g . new onset angina ) would , judgment investigator , interfere safe conduct study . Patients enrol protocol involve investigational drug surgery . Severe depression : Geriatric Depression Scale score great equal 13 . Pregnancy breast feeding .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2005</verification_date>
	<keyword>Mild Dementia</keyword>
	<keyword>Acetylcholine</keyword>
	<keyword>Memory</keyword>
	<keyword>Hallucinations</keyword>
	<keyword>Washout</keyword>
	<keyword>Parkinson Disease</keyword>
	<keyword>Parkinson 's Disease</keyword>
	<keyword>PD</keyword>
	<keyword>Dementia</keyword>
</DOC>